Related Experiment Videos

Determination of the age-related changes of serum basic fibroblast growth factor (bFGF) level in healthy Japanese

Yoshihiro Okamoto1, Mayuri Tanaka, Nobuhiro Miyahara

  • 1Laboratory of Immunology and Microbiology, Faculty of Pharmacy, Chiba Institute of Science, 3 Shiomi-cho, Choshi, Chiba 288-0025, Japan. yokamoto@cis.ac.jp

Clinical Laboratory
|May 26, 2009
PubMed

Insights

Serum basic fibroblast growth factor (bFGF) levels were established for healthy Japanese individuals. No significant differences were found between children and adults, but children

Area of Science:

  • Biochemistry
  • Pediatrics
  • Clinical Chemistry

Background:

  • Serum basic fibroblast growth factor (bFGF) is a crucial protein involved in cell growth and repair.
  • Establishing reliable reference values for bFGF is essential for clinical diagnostics, particularly in pediatric cases.
  • Previous studies have not comprehensively defined age-specific reference ranges for bFGF in healthy populations.

Purpose of the Study:

  • To determine the serum bFGF levels in healthy Japanese individuals to establish reference values.
  • To compare serum bFGF levels between children and adults.
  • To validate the clinical utility of established bFGF reference values in a pediatric patient with Hemolytic Uremic Syndrome (HUS).

Main Methods:

  • Serum samples from healthy Japanese individuals (children and adults) were analyzed using a specific human bFGF ELISA (Enzyme-Linked Immunosorbent Assay).
  • Statistical analyses were performed to compare bFGF levels between age groups and to determine reference ranges.
  • Serum bFGF levels of a pediatric patient with diarrhea-positive (D+) HUS were measured and compared to healthy controls.

Main Results:

  • No significant differences in serum bFGF levels were observed between healthy children and adults.
  • The reference value range for serum bFGF was broader in children compared to adults.
  • The pediatric HUS patient exhibited markedly elevated serum bFGF levels from the onset of the condition compared to healthy children.

Conclusions:

  • Established reference values for serum bFGF in healthy Japanese individuals are now available.
  • Age-matched controls are recommended for accurate evaluation of patient serum bFGF levels.
  • The study highlights the potential of serum bFGF levels as a biomarker for distinguishing normal physiological states from pathological conditions like pediatric HUS.